Viewing Study NCT03510468


Ignite Creation Date: 2025-12-24 @ 6:28 PM
Ignite Modification Date: 2026-01-05 @ 6:36 PM
Study NCT ID: NCT03510468
Status: COMPLETED
Last Update Posted: 2024-08-13
First Post: 2018-04-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Impact of Weekly Administration of Rifapentine and Isoniazid on Steady State Pharmacokinetics of Tenofovir Alafenamide in Healthy Volunteers (YODA)
Sponsor: National Institutes of Health Clinical Center (CC)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: 180087
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators